Financial Survey: Sensus Healthcare (NASDAQ:SRTS) vs. SONOVA (OTCMKTS:SONVY)

SONOVA (OTCMKTS:SONVY) and Sensus Healthcare (NASDAQ:SRTS) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability.

Valuation & Earnings

This table compares SONOVA and Sensus Healthcare”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SONOVA	$4.36 billion	3.98	$610.01 million	N/A	N/A
Sensus Healthcare	$41.81 million	1.64	$6.65 million	$0.10	41.60

SONOVA has higher revenue and earnings than Sensus Healthcare.

Risk & Volatility

SONOVA has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.29, meaning that its stock price is 29% more volatile than the S&P 500.

Institutional & Insider Ownership

0.0% of SONOVA shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 0.0% of SONOVA shares are held by insiders. Comparatively, 8.9% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and recommmendations for SONOVA and Sensus Healthcare, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SONOVA	4	4	0	0	1.50
Sensus Healthcare	0	0	3	0	3.00

Sensus Healthcare has a consensus price target of $11.67, indicating a potential upside of 180.45%. Given Sensus Healthcare’s stronger consensus rating and higher possible upside, analysts plainly believe Sensus Healthcare is more favorable than SONOVA.

Profitability

This table compares SONOVA and Sensus Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SONOVA	N/A	N/A	N/A
Sensus Healthcare	4.56%	3.34%	3.00%

Summary

Sensus Healthcare beats SONOVA on 9 of the 12 factors compared between the two stocks.

About SONOVA

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

About Sensus Healthcare

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.